The following guidelines sections have been re-drafted and supplied for posting; others will follow later this week. Please note that full references are not available for all drafts.
- EvidenceWhen to start (please note that this section has been extensively revised)What to start withInitial failureAdherenceSalvage therapyResistanceMetabolic complications of therapy: Mitochondrial toxicityLipodystrophyTherapeutic drug monitoring
Process for revising the BHIVA adult antiretroviral treatment guidelines, 2001
These drafts will be revised before April 24 by the Writing Committee, after which a new draft will be made available for online discussion.
Please send any further comments to Dr Anton Pozniak.
Comments will be integrated into a second draft for discussion.